ADURO BIOTECH, INC. (38) | Intellectual Property (2)
- License Agreement, dated December 16, 2019, by and between Chinook Therapeutics U.S., Inc. and AbbVie Ireland Unlimited Company (Filed With SEC on July 22, 2020)
- Amendment No. 3 to Exclusive License Agreement between Aduro Biotech, Inc. and the Memorial Sloan Kettering Cancer Center, dated March 30, 2020 (Filed With SEC on May 4, 2020)
